newsfilter
← Latest News
GlobeNewswire·

Evelo Biosciences Provides Updated Guidance on Advancing Clinical Inflammation Programs

–Guidance on registration trials for EDP1815 in psoriasis expected in 3Q 2022––Data from initial cohort of patients in Phase 2 trial of EDP1815 in atopic dermatitis expected 1Q 2023––Faster release capsule cohort to be added to on-going Phase 2